PH12022550181A1 - Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions - Google Patents

Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions

Info

Publication number
PH12022550181A1
PH12022550181A1 PH1/2022/550181A PH12022550181A PH12022550181A1 PH 12022550181 A1 PH12022550181 A1 PH 12022550181A1 PH 12022550181 A PH12022550181 A PH 12022550181A PH 12022550181 A1 PH12022550181 A1 PH 12022550181A1
Authority
PH
Philippines
Prior art keywords
tmem16a
modulators
treatment
pyridine derivatives
respiratory conditions
Prior art date
Application number
PH1/2022/550181A
Other languages
English (en)
Inventor
Craig Buxton
Stephen Collingwood
Jonathan David Hargrave
Peter Ingram
Thomas Beauregard Schofield
Abdul Shaikh
Christopher Stimson
Original Assignee
Tmem16A Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1910607.9A external-priority patent/GB201910607D0/en
Priority claimed from GBGB2005739.4A external-priority patent/GB202005739D0/en
Application filed by Tmem16A Ltd filed Critical Tmem16A Ltd
Publication of PH12022550181A1 publication Critical patent/PH12022550181A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PH1/2022/550181A 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions PH12022550181A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1910607.9A GB201910607D0 (en) 2019-07-24 2019-07-24 Compounds
GBGB2005739.4A GB202005739D0 (en) 2020-04-20 2020-04-20 Compounds
PCT/GB2020/051778 WO2021014166A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions

Publications (1)

Publication Number Publication Date
PH12022550181A1 true PH12022550181A1 (en) 2023-01-16

Family

ID=71948615

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2022/550181A PH12022550181A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions

Country Status (16)

Country Link
US (1) US20220235006A1 (cg-RX-API-DMAC10.html)
EP (1) EP4003516A1 (cg-RX-API-DMAC10.html)
JP (1) JP7583022B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220063162A (cg-RX-API-DMAC10.html)
CN (1) CN114616226B (cg-RX-API-DMAC10.html)
AU (1) AU2020317036A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022001164A2 (cg-RX-API-DMAC10.html)
CA (1) CA3145120A1 (cg-RX-API-DMAC10.html)
CL (1) CL2022000147A1 (cg-RX-API-DMAC10.html)
CO (1) CO2022002022A2 (cg-RX-API-DMAC10.html)
CR (1) CR20220072A (cg-RX-API-DMAC10.html)
IL (1) IL290035A (cg-RX-API-DMAC10.html)
MX (1) MX2022000841A (cg-RX-API-DMAC10.html)
PE (1) PE20221441A1 (cg-RX-API-DMAC10.html)
PH (1) PH12022550181A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021014166A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4003516A1 (en) * 2019-07-24 2022-06-01 Tmem16A Limited Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions
KR20260025059A (ko) * 2024-08-13 2026-02-23 전남대학교산학협력단 신규한 치환된 피리딘 유도체 화합물, 이의 제조방법, 및 이를 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042524A1 (en) 2003-10-30 2005-05-12 Virochem Pharma Inc. Pyridine carboxamide and methods for inhibiting hiv integrase
EP3612180B1 (en) 2017-04-17 2023-10-11 The Regents of the University of California Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel tmem16a
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds
EP4003516A1 (en) * 2019-07-24 2022-06-01 Tmem16A Limited Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions

Also Published As

Publication number Publication date
CN114616226A (zh) 2022-06-10
BR112022001164A2 (pt) 2022-03-15
IL290035A (en) 2022-03-01
WO2021014166A1 (en) 2021-01-28
US20220235006A1 (en) 2022-07-28
JP2022541311A (ja) 2022-09-22
AU2020317036A1 (en) 2022-03-17
KR20220063162A (ko) 2022-05-17
CO2022002022A2 (es) 2022-06-10
PE20221441A1 (es) 2022-09-21
CN114616226B (zh) 2025-03-04
MX2022000841A (es) 2022-06-08
CA3145120A1 (en) 2021-01-28
CR20220072A (es) 2022-06-29
EP4003516A1 (en) 2022-06-01
JP7583022B2 (ja) 2024-11-13
CL2022000147A1 (es) 2022-10-07

Similar Documents

Publication Publication Date Title
ZA202001717B (en) Compounds, salts thereof and methods for treatment of diseases
PH12021553233A1 (en) Imidazopyrimidines as eed inhibitors and the use thereof
PH12020551578A1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
ZA202500997B (en) Benzoxazepin oxazolidinone compounds and methods of use
PH12020551327A1 (en) Compounds
PH12020500509A1 (en) Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
MX2020001833A (es) Moduladores de piruvato quinasas y uso de los mismos.
EP4497474A3 (en) Methods of treating rheumatic diseases using trimetazidine-based compounds
DE602004019198D1 (de) Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
PH12015501740A1 (en) Sodium channel modulators for the treatment of pain
PH12021500034A1 (en) Compounds useful in hiv therapy
DK2215058T3 (da) Substituerede N-phenylbipyrrolidinureaer og terapeutisk anvendelse deraf
MY209256A (en) Compounds affecting pigment production and use thereof for treatment of bacterial diseases
EP4427815A3 (en) Deuterium-enriched pirfenidone and methods of use thereof
MX2017017171A (es) Compuestos terapeuticos y composiciones para el tratamiento de trastornos sociales y trastornos de uso de sustancias.
MD20150075A2 (ro) Compuşi tetraciclici heterociclu-substituiţi şi metode de utilizare a acestora pentru tratamentul bolilor virale
EA201891377A1 (ru) ПРИМЕНЕНИЕ МОДУЛЯТОРОВ КАНАЛОВ Kv3.1/Kv3.2/Kv3.3 ДЛЯ ЛЕЧЕНИЯ БОЛИ
EA201991253A1 (ru) Бензодиазолиевые соединения в качестве ингибиторов enac
PH12022550078A1 (en) Enzyme inhibitors
CL2024000742A1 (es) Compuestos moduladores de gpr52
CO2022002022A2 (es) Derivados de piridina como moduladores de tmem16a para su uso en el tratamiento de afecciones respiratorias
WO2019040104A3 (en) COMPOUNDS, RELATED SALTS AND METHODS OF TREATING DISEASES
PH12016501645A1 (en) Aminopyrazolone derivative
PH12018502680A1 (en) Crystal forms of 9-aminomethyl substituted tetracycline compound and preparation method thereof